Search
InterCure Ltd
INCRAdd to Watchlist
1.090USD
-0.040-3.54%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
59.60MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-3.54%
5 Days
+9.00%
1 Month
+1.87%
6 Months
+19.78%
Year to Date
+19.78%
1 Year
-26.35%
Key Figures
1.090Open
1.140High
279.00Volume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.00%Turnover Ratio
1.130Prev. Close
1.090Low
310.00Turnover
LossP/E Static
0.44P/B
0.00%Div Yield TTM
-7.28%ROA
605.00052wk High
-0.02Volume Ratio
-67.80MNet Profit
54.68MShares
-0.3776EPS TTM
1.12Beta
-12.96%ROE
225.30052wk Low
4.42%Amplitude
30.47%Gross Margin
59.60MMarket Cap
3.51Reward/Risk
2.77%Risk Rate
TradingKey Stock Score of InterCure Ltd
Currency: USD Updated: 2026-07-01Key Insights
InterCure Ltd's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered undervalued, ranking 68 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and strong technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
InterCure Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive+
InterCure Ltd Highlights
StrengthsRisks
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Growing
The company is in a growing phase, with the latest annual income totaling USD 91.95M.
Undervalued
The company’s latest PE is -2.99, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 620.62K shares, decreasing 86.46% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.12.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
InterCure Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
InterCure Ltd Info
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Ticker SymbolINCR
CompanyInterCure Ltd
CEOMimon (Ori)
Websitehttps://www.intercure.co/
Related Instruments
+0.06%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+0.56%
0.00%
+1.10%
0.00%
0.00%
0.00%
+0.84%
+0.98%
0.00%Popular Instruments
52385.200
+130.900 (+0.25%)
29880.400
+81.100 (+0.27%)
7494.800
+19.300 (+0.26%)
14802.000
-553.000 (-3.60%)
69076.000
-409.000 (-0.59%)
6340.800
+65.400 (+1.04%)
67.054
-0.914 (-1.34%)
295.250
+0.870 (+0.30%)
196.500
-1.080 (-0.55%)
4063.580
+32.810 (+0.81%)
FAQs
What is the current price of InterCure Ltd (INCR)?
The current price of InterCure Ltd (INCR) is 1.13.
What is the symbol of InterCure Ltd?
The ticker symbol of InterCure Ltd is INCR.
What is the 52-week high of InterCure Ltd?
The 52-week high of InterCure Ltd is 605.00.
What is the 52-week low of InterCure Ltd?
The 52-week low of InterCure Ltd is 225.30.
What is the market capitalization of InterCure Ltd?
The market capitalization of InterCure Ltd is 67.19M.
What is the Earnings Per Share (EPS TTM) of InterCure Ltd (INCR)?
The Earnings Per Share (EPS TTM) of InterCure Ltd (INCR) is -0.21.